Schiavoni L, Mattei A, Pascarella G, Piliego C, Biondo G, Strumia A, Agrò Felice E
Unit of Anesthesia, Intensive Care and Pain Management, Department of Medicine, Università Campus Bio-Medico di Roma, via Álvaro del Portillo 21, 00128 Rome, Italy.
Unit of Anesthesia, Intensive Care and Pain Management, Department of Medicine, Ospedale di Velletri, Via Orti Ginnetti n.7, 00049 Velletri, RM, Italy.
Obes Res Clin Pract. 2022 Jul-Aug;16(4):346-348. doi: 10.1016/j.orcp.2022.07.008. Epub 2022 Jul 28.
The ELSO Guidelines list a BMI ≥ 40 kg/m among the relative contraindications to give ECMO treatment in SARS - COV2 patients. We describe a case of a 52-year-old with BMI 50.21 kg/m, admitted to the intensive care unit (ICU) with severe respiratory conditions and successfully treated with extracorporeal membrane oxygenation (ECMO). The application of veno-venous (VV) ECMO will evolve as far as we understand the pathophysiology of the COVID-19 disease and will probably have a determinant role in management of patient with refractory hypoxemia, whose ventilation management is difficult, even in case of severe obesity.
体外生命支持组织（ELSO）指南将BMI≥40kg/m²列为2019冠状病毒病（SARS-CoV2）患者接受体外膜肺氧合（ECMO）治疗的相对禁忌证。我们报告一例52岁、BMI为50.21kg/m²的患者，因严重呼吸疾病入住重症监护病房（ICU），并成功接受了体外膜肺氧合（ECMO）治疗。就我们对2019冠状病毒病病理生理学的理解而言，静脉-静脉（VV）ECMO的应用将会不断发展，并且在难治性低氧血症患者的管理中可能具有决定性作用，即使是在严重肥胖的情况下，这类患者的通气管理也很困难。
